143
Views
12
CrossRef citations to date
0
Altmetric
Review

Complement Inhibition and COVID-19: The Story so Far

& ORCID Icon
Pages 273-284 | Published online: 26 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Anusha Chidharla, Salman B Syed, Tulika Chatterjee & Michael D Tarantino. (2021) A Case Report of COVID-Associated Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab. Journal of Blood Medicine 12, pages 929-933.
Read now

Articles from other publishers (11)

Kathryn B. Holroyd & Sarah E. Conway. (2023) Central Nervous System Neuroimmunologic Complications of COVID-19. Seminars in Neurology 43:02, pages 229-250.
Crossref
Arutha Kulasinghe, Ning Liu, Chin Wee Tan, James Monkman, Jane E. Sinclair, Dharmesh D. Bhuva, David Godbolt, Liuliu Pan, Andy Nam, Habib Sadeghirad, Kei Sato, Gianluigi Li Bassi, Ken O'Byrne, Camila Hartmann, Anna Flavia Ribeiro dos Santos Miggiolaro, Gustavo Lenci Marques, Lidia Zytynski Moura, Derek Richard, Mark Adams, Lucia de Noronha, Cristina Pellegrino Baena, Jacky Y. Suen, Rakesh Arora, Gabrielle T. Belz, Kirsty R. Short, Melissa J. Davis, Fernando Souza‐Fonseca Guimaraes & John F. Fraser. (2022) Transcriptomic profiling of cardiac tissues from SARS‐CoV ‐2 patients identifies DNA damage . Immunology 168:3, pages 403-419.
Crossref
Matija Matošević, Ivanka Kos, Maša Davidović, Maja Ban, Hana Matković, Ivan Jakopčić, Ivana Vuković Brinar, Ágnes Szilágyi, Dorottya Csuka, György Sinkovits, Zoltán Prohászka, Kristina Vrljičak & Lovro Lamot. (2023) Hemolytic uremic syndrome in the setting of COVID-19 successfully treated with complement inhibition therapy: An instructive case report of a previously healthy toddler and review of literature. Frontiers in Pediatrics 11.
Crossref
Giuseppe Remuzzi, Stefano Schiaffino, Maria Gabriella Santoro, Garret A. FitzGerald, Gennaro Melino & Carlo Patrono. (2022) Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years. Frontiers in Pharmacology 13.
Crossref
Pascal Urwyler, Stephan Moser, Marten Trendelenburg, Parham Sendi & Michael Osthoff. (2022) Targeting thromboinflammation in COVID-19 – A narrative review of the potential of C1 inhibitor to prevent disease progression. Molecular Immunology 150, pages 99-113.
Crossref
Panagiotis Skendros, Georgios Germanidis, Dimitrios C. Mastellos, Christina Antoniadou, Efstratios Gavriilidis, Georgios Kalopitas, Anna SamakidouAngelos Liontos, Akrivi ChrysanthopoulouMaria NtinopoulouDionysios Kogias, Ioanna KaranikaAndreas Smyrlis, Dainora Cepaityte, Iliana Fotiadou, Nikoleta Zioga, Ioannis MitroulisNikolaos K. Gatselis, Charalampos Papagoras, Simeon MetallidisHaralampos Milionis, George N. Dalekos, Loek WillemsBarbro PerssonVivek Anand Manivel, Bo NilssonE. Sander ConnollySimona IacobelliVasileios Papadopoulos, Rodrigo T. Calado, Markus Huber-Lang, Antonio M. RisitanoDespina YancopoulouKonstantinos RitisJohn D. Lambris. (2022) Complement C3 inhibition in severe COVID-19 using compstatin AMY-101. Science Advances 8:33.
Crossref
William R. Strohl, Zhiqiang Ku, Zhiqiang An, Stephen F. Carroll, Bruce A. Keyt & Lila M. Strohl. (2022) Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants. BioDrugs 36:3, pages 231-323.
Crossref
Bruno Fattizzo, Raffaella Pasquale, Valentina Bellani, Wilma Barcellini & Austin G. Kulasekararaj. (2021) Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature. Frontiers in Immunology 12.
Crossref
Chiara Agostinis, Alessandro Mangogna, Andrea Balduit, Azin Aghamajidi, Giuseppe Ricci, Uday Kishore & Roberta Bulla. (2021) COVID-19, Pre-Eclampsia, and Complement System. Frontiers in Immunology 12.
Crossref
Camila Lopes Veronez, Sandra C. Christiansen, Tukisa D. Smith, Marc A. Riedl & Bruce L. Zuraw. (2021) COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications. Allergy and Asthma Proceedings 42:6, pages 506-514.
Crossref
Federica Defendi, Corentin Leroy, Olivier Epaulard, Giovanna Clavarino, Antoine Vilotitch, Marion Le Marechal, Marie-Christine Jacob, Tatiana Raskovalova, Martine Pernollet, Audrey Le Gouellec, Jean-Luc Bosson, Pascal Poignard, Matthieu Roustit, Nicole Thielens, Chantal Dumestre-Pérard & Jean-Yves Cesbron. (2021) Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality. Frontiers in Immunology 12.
Crossref